Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma

The determinants of immune checkpoint blockade (ICB) response in glioblastoma (GBM) with wild-type isocitrate dehydrogenase remain poorly understood. Here we pr...